TickerFactsScreenerDevelopers

Foghorn Therapeutics Inc. (FHTX) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2019: $14.98M2020: $92.80M2021: $101.14M2022: $52.21M2023: $80.34M2024: $55.45M2025: $80.88M$80.88M
2019Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$80.88M+45.8%
2024$55.45M-31.0%
2023$80.34M+53.9%
2022$52.21M-48.4%
2021$101.14M+9.0%
2020$92.80M+519.4%
2019$14.98M—